Thoratec Corporation

Skip to content


Executive Officers

Gerhard F. Burbach

President, Chief Executive Officer, and Director

Gerhard Burbach joined Thoratec as president and chief executive officer in January 2006, at which time he was appointed to the board of directors. Prior to his arrival, Burbach served as president and chief executive officer of Digirad Corporation, a leading provider in solid-stage cardiology and nuclear medicine imaging products and services. Burbach has held executive positions at Bacchus Vascular Inc. and Philips Nuclear Medicine, as well as the consulting firm of McKinsey & Company, Inc. He has a bachelor's degree in industrial engineering from Stanford University and a master's degree in business administration from Harvard Business School. In addition to the Thoratec Board of Directors, also serves on the boards of Fluidigm Corporation and AdvaMed.

David A. Lehman

Senior Vice President and General Counsel

David Lehman joined Thoratec as vice president, general counsel and secretary in May 2003 and became senior vice president in 2007. Prior to his arrival, he was Vice President and General Counsel at Brigade Corporation, a business process outsourcing company, and previously held positions in the legal departments of Bio-Rad Laboratories, Inc., a life science research and clinical diagnostics company, and Mitsubishi International Corporation, a Japanese trading company, in their New York and Tokyo offices. He began his career as an associate attorney at the law firm of Hall, Dickler, Kent, Friedman & Wood in New York. He has a bachelor's degree in political science from The University of California, San Diego and a J.D. from Cornell University Law School.

Taylor Harris

Vice President and Chief Financial Officer

Taylor Harris joined Thoratec in 2010 as Senior Director of Investor Relations and Business Development. Prior to joining Thoratec, he worked at JPMorgan Chase & Co. for over a decade in several capacities, including as a Vice President in the firm's Healthcare Investment Banking and Equity Research departments. In these roles, he covered the medical device sector as an investment research analyst and advised healthcare companies on a broad range of strategic and capital markets transactions. He holds a B.A. in Physics and Economics from the University of North Carolina at Chapel Hill.

Board of Directors

Neil F. Dimick

Chairman of the Board, Executive Vice President and Chief Financial Officer (retired), AmerisourceBergen Corporation
Laguna Hills, California

Gary F. Burbach

President, Chief Executive Officer, Thoratec Corporation

J. Daniel Cole

General Partner, Spray Venture Fund
Boston, Massachusetts

Steven H. Collis

President and Chief Executive Officer, AmerisourceBergen Corporation
Valley Forge, Pennsylvania

D. Keith Grossman

President and Chief Executive Officer Conceptus Inc.
Mountain View, California

William A. Hawkins, III

President and Chief Executive Officer Immucor, Inc.
Norcross, Georgia

Paul A. LaViolette

Partner, SV Life Sciences
Boston, Massachusetts

Daniel M. Mulvena

Founder and Owner, Commodore Associates
Wilmington, Delaware

Todd Schermerhorn

Chief Financial Officer (retired) CR Bard
Mendham, New Jersey

Next: Media Room

Text Size: A A A